• レポートコード:PMR2009006 • 出版社/出版日:Persistence Market Research / 2020年7月22日 • レポート形態:英文、PDF、201ページ • 納品方法:Eメール • 産業分類:医薬品 |
Individual User(1名用) | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User(5名用) | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User(企業用) | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、リポソームの世界市場を徹底調査するとともに、エグゼクティブサマリー、市場概要、主要市場動向、市場状況、市場背景、価格分析・予測、製品別(単一リポソーム、配合リポソーム、ワクチン)分析、用途別(ドラッグデリバリー、遺伝子デリバリー/トランスフェクション、医療用造影剤、モデル細胞膜)分析、流通チャネル別(小売販売、流通販売)分析、地域別分析、競争分析、仮定、調査手法などを明らかに致します。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場状況 ・市場背景 ・価格分析・予測 ・リポソームの世界市場規模:製品別(単一リポソーム、配合リポソーム、ワクチン) ・リポソームの世界市場規模:用途別(ドラッグデリバリー、遺伝子デリバリー/トランスフェクション、医療用造影剤、モデル細胞膜) ・リポソームの世界市場規模:流通チャネル別(小売販売、流通販売) ・リポソームの世界市場規模:地域別 ・競争分析 ・仮定 ・調査手法 |
Liposomes Market – Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global liposomes market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the liposomes market structure. The market study presents exclusive information about how the liposomes market will grow during the forecast period of 2020-2030.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis by region and by product, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the liposomes market during the forecast period.
The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the liposomes market. Furthermore, small businesses and new entrants in the liposomes market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Key Questions Answered in PMR’s Liposomes Market Report
Which regions will continue to remain the most profitable regional markets for liposomes market players?
Which factors will induce a change in the demand for liposomes during the assessment period?
What are the different opportunities available for emerging players in the liposomes market?
How are supply-side and demand-side drivers impacting the liposomes market?
How will changing trends impact the liposomes market?
How can market players capture the low-hanging opportunities in the liposomes market in developed regions?
Which companies are leading the liposomes market?
What are the winning strategies of stakeholders in the liposomes market to upscale their position in this landscape?
Liposomes Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the liposomes market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the liposomes market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the liposomes market, and makes PMR’s projections on the growth prospects of the liposomes market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Regulatory Scenario
4.2. Global Liposomes Market – Key Promotional Strategies
4.3. Porter’s Five Forces Analysis
4.4. Cancer Epidemiology Analysis
5. Market Background
5.1. Macro-Economic Factors
5.2. Forecast Factors – Relevance & Impact
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity
5.4. COVID19 Crisis Analysis
5.4.1. Current COVID19 Statistics and Probable Future Impact
5.4.2. Current GDP Projection and Probable Impact
5.4.3. Current Economic Projection as compared to 2008 Economic analysis
5.4.4. COVID19 and Impact Analysis
5.4.4.1. Revenue By Product
5.4.4.2. Revenue By Country
5.4.5. 2020 Market Scenario
5.4.6. Quarter by Quarter Forecast
5.4.7. Projected recovery Quarter
5.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Global Liposomes Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020-2030
7. Global Liposomes Market Analysis 2015-2019 and Forecast 2020-2030 by Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product, 2015–2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030
7.3.1. Simple Liposomes
7.3.2. Formulated Liposomes
7.3.2.1. Doxorubicin Liposomes
7.3.2.2. Amphotericin B Liposomes
7.3.2.3. Paclitaxel Liposomes
7.3.2.4. Cytarabine Liposomes
7.3.2.5. Irinotecan Liposomes
7.3.2.6. Cisplatin Liposomes
7.3.2.7. Others
7.3.3. Vaccines
7.4. Market Attractiveness Analysis By Product
8. Global Liposomes Market Analysis 2015-2019 and Forecast 2020-2030 by Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2020-2030
8.3.1. Drug delivery
8.3.1.1. Cancer
8.3.1.2. Fungal Infection
8.3.1.3. Viral & Parasite Infection
8.3.1.4. Others
8.3.2. Gene Delivery/Transfection
8.3.3. Contrast agents for medical imaging
8.3.4. Model Cell Membranes
8.4. Market Attractiveness Analysis By Application
9. Global Liposomes Market Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
9.3.1. Retail Sales
9.3.1.1. Academic & Research Laboratories
9.3.1.2. Biopharmaceutical Companies
9.3.1.3. Clinical Research Organizations
9.3.1.4. Others
9.3.2. Distributional Sales
9.3.2.1. Hospital Pharmacies
9.3.2.2. Retail Pharmacies
9.3.2.3. Mail Order Pharmacies
9.3.2.4. Drug Stores
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Liposomes Market Analysis 2015-2019 and Forecast 2020-2030 by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Application
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
12. Latin America Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Application
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
13. Europe Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Product
13.3.3. By Application
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
14. South Asia Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Product
14.3.3. By Application
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
15. East Asia Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Application
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
16. Oceania Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Application
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
17. Middle East and Africa Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. South Africa
17.3.1.4. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Application
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
18. Emerging & Key Countries Liposomes Market Analysis 2015-2019 and Forecast 2020-2030
18.1. U.S. Liposomes Market Analysis
18.1.1. By Product
18.1.2. By Application
18.1.3. By Distribution Channel
18.2. Canada Liposomes Market Analysis
18.2.1. By Product
18.2.2. By Application
18.2.3. By Distribution Channel
18.3. Mexico Liposomes Market Analysis
18.3.1. By Product
18.3.2. By Application
18.3.3. By Distribution Channel
18.4. Brazil Liposomes Market Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By Distribution Channel
18.5. U.K. Liposomes Market Analysis
18.5.1. By Product
18.5.2. By Application
18.5.3. By Distribution Channel
18.6. Germany Liposomes Market Analysis
18.6.1. By Product
18.6.2. By Application
18.6.3. By Distribution Channel
18.7. France Liposomes Market Analysis
18.7.1. By Product
18.7.2. By Application
18.7.3. By Distribution Channel
18.8. Italy Liposomes Market Analysis
18.8.1. By Product
18.8.2. By Application
18.8.3. By Distribution Channel
18.9. Spain Liposomes Market Analysis
18.9.1. By Product
18.9.2. By Application
18.9.3. By Distribution Channel
18.10. Russia Liposomes Market Analysis
18.10.1. By Product
18.10.2. By Application
18.10.3. By Distribution Channel
18.11. China Liposomes Market Analysis
18.11.1. By Product
18.11.2. By Application
18.11.3. By Distribution Channel
18.12. India Liposomes Market Analysis
18.12.1. By Product
18.12.2. By Application
18.12.3. By Distribution Channel
18.13. Japan Liposomes Market Analysis
18.13.1. By Product
18.13.2. By Application
18.13.3. By Distribution Channel
18.14. South Korea Liposomes Market Analysis
18.14.1. By Product
18.14.2. By Application
18.14.3. By Distribution Channel
18.15. Thailand Liposomes Market Analysis
18.15.1. By Product
18.15.2. By Application
18.15.3. By Distribution Channel
18.16. Australia Liposomes Market Analysis
18.16.1. By Product
18.16.2. By Application
18.16.3. By Distribution Channel
18.17. Malaysia Liposomes Market Analysis
18.17.1. By Product
18.17.2. By Application
18.17.3. By Distribution Channel
18.18. GCC Countries Liposomes Market Analysis
18.18.1. By Product
18.18.2. By Application
18.18.3. By Distribution Channel
18.19. Turkey Liposomes Market Analysis
18.19.1. By Product
18.19.2. By Application
18.19.3. By Distribution Channel
18.20. South Africa Liposomes Market Analysis
18.20.1. By Product
18.20.2. By Application
18.20.3. By Distribution Channel
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Pfizer Inc.
19.2.2. Novartis AG
19.2.3. Teva Pharmaceutical Industries Ltd
19.2.4. Johnson & Johnson
19.2.5. Dr. Reddy’s Laboratories Ltd.
19.2.6. Sun Pharma Industries Ltd
19.2.7. Baxter AG
19.2.8. Sanofi SA
19.2.9. Bristol Myers Squibb
19.2.10. Mylan NV
19.2.11. GlaxoSmithKline Plc.
19.2.12. Creative Biolabs
19.2.13. Precision NanoSystems Inc.
19.2.14. SkyePharma Inc.
19.2.15. Luye Pharma Group
19.2.16. Encapsula NanoSciences LLC
19.2.17. Nanovex Biotechnologies SL
19.2.18. Gilead Sciences, Inc.
19.2.19. Avanti Polar Lipids, Inc.
19.2.20. Fujifilm Holdings Corporation
20. Assumptions and Acronyms Used
21. Research Methodology
List of Tables:Table 01: Global Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 02: Global Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 03: Global Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 04: Global Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Region
Table 05: North America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 06: North America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 07: North America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 08: North America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 09: Latin America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 10: Latin America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 11: Latin America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 12: Latin America Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 13: Europe Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 14: Europe Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 15: Europe Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 16: Europe Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 17: South Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 18: South Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 19: South Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 20: South Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 21: East Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 22: East Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 23: East Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 24: East Asia Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 25: Oceania Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 26: Oceania Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 27: Oceania Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 28: Oceania Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel
Table 29: Middle East & Africa Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Country
Table 30: Middle East & Africa Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Product
Table 31: Middle East & Africa Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Application
Table 32: Middle East & Africa Liposomes Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030 by Distribution Channel